Candesartan in migraine prevention: results from a retrospective real-world study
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Neurology"
DOI: 10.1007/s00415-020-09989-9
Abstract: Randomized studies have reported a positive effect of candesartan, an angiotensin II receptor antagonist, in migraine prevention. The aim of our study was to explore patient subjective efficacy of candesartan in a real-world sample of… read more here.
Keywords: migraine; candesartan; real world; study ... See more keywords
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
Sign Up to like & getrecommendations! Published in 2017 at "Current Treatment Options in Neurology"
DOI: 10.1007/s11940-017-0463-4
Abstract: Opinion statementMigraine is a very disabling disorder with severe impact on patients’ lives and substantive costs to society in terms of healthcare costs and lost productivity. Prevention is a key component of migraine therapy, and… read more here.
Keywords: migraine; monoclonal antibodies; era; phase iii ... See more keywords
Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs
Sign Up to like & getrecommendations! Published in 2018 at "Drugs"
DOI: 10.1007/s40265-018-0865-y
Abstract: Migraine is a common and disabling neurological disorder, with a significant socioeconomic burden. Its pathophysiology involves abnormalities in complex neuronal networks, interacting at different levels of the central and peripheral nervous system, resulting in the… read more here.
Keywords: drugs recent; advances pharmacotherapy; pathophysiology; recent advances ... See more keywords
Clinical benefits and economic cost-savings of Remote Electrical Neuromodulation (REN) for migraine prevention.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of medical economics"
DOI: 10.1080/13696998.2023.2205751
Abstract: AIMS Assess the clinical benefits and associated direct and indirect cost-savings from Remote Electrical Neuromodulation (REN) for migraine prevention. METHODS REN, a prescribed, wearable, FDA-cleared neuromodulation-device for the acute and/or treatment of migraine, recently demonstrated… read more here.
Keywords: clinical benefits; cost; cost savings; migraine prevention ... See more keywords
Percutaneous Interventional Strategies for Migraine Prevention: A Systematic Review and Practice Guideline.
Sign Up to like & getrecommendations! Published in 2021 at "Pain medicine"
DOI: 10.1093/pm/pnab236
Abstract: OBJECTIVE To systematically evaluate the efficacy and effectiveness of percutaneous interventional treatments for prevention of migraine through a qualitative and (when possible) quantitative analysis. METHODS An expert panel was asked to develop recommendations for the… read more here.
Keywords: percutaneous interventional; review; interventional strategies; migraine prevention ... See more keywords
The Physiology of Migraine and its Prevention by Nutrition
Sign Up to like & getrecommendations! Published in 2023 at "Physiology"
DOI: 10.1152/physiol.2023.38.s1.5728950
Abstract: Migraine is a genetic condition associated with hypersensitive sensory neurons, more sensory neuronal connections, and different electrical properties than a non-migraine brain[1, 2]. Migraineurs waste 50% more sodium in their urine than typical subjects[3]. The… read more here.
Keywords: prevention nutrition; physiology migraine; migraine; brain ... See more keywords
Trajectory of treatment response in the child and adolescent migraine prevention (CHAMP) study: A randomized clinical trial
Sign Up to like & getrecommendations! Published in 2021 at "Cephalalgia"
DOI: 10.1177/03331024211033551
Abstract: Objective Identify preventive medication treatment response trajectories among youth participating in the Childhood and Adolescent Migraine Prevention study. Methods Data were evaluated from 328 youth (ages 8–17). Childhood and Adolescent Migraine Prevention study participants completed… read more here.
Keywords: treatment response; trial; migraine prevention; treatment ... See more keywords
“Wearing-off” efficacy of CGRP monoclonal antibodies for migraine prevention: A meta-analysis of randomized controlled trials
Sign Up to like & getrecommendations! Published in 2023 at "Cephalalgia"
DOI: 10.1177/03331024231161261
Abstract: Background A new migraine prevention, CGRP monoclonal antibodies (mAbs), is injectable on a monthly or quarterly basis. In clinical practice, some patients reported that drug effectiveness does not last until the upcoming scheduled injection, a… read more here.
Keywords: meta analysis; cgrp monoclonal; effect; migraine prevention ... See more keywords
The importance of an early onset of migraine prevention: an evidence-based, hypothesis-driven scoping literature review
Sign Up to like & getrecommendations! Published in 2022 at "Therapeutic Advances in Neurological Disorders"
DOI: 10.1177/17562864221095902
Abstract: Recently approved migraine preventive therapies facilitate rapid control of migraine activity, potentially improving patients’ lives and minimizing the societal burden of migraine. This review synthesizes available evidence on rates and timing of early onset of… read more here.
Keywords: prevention; early onset; migraine; migraine prevention ... See more keywords
Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention
Sign Up to like & getrecommendations! Published in 2019 at "Neurology"
DOI: 10.1212/wnl.0000000000008105
Abstract: Objective To provide updated evidence-based recommendations for migraine prevention using pharmacologic treatment with or without cognitive behavioral therapy in the pediatric population. Methods The authors systematically reviewed literature from January 2003 to August 2017 and… read more here.
Keywords: migraine prevention; neurology; headache frequency; headache ... See more keywords
Migraine Prevention with Erenumab: Focus on Patient Selection, Perspectives and Outcomes
Sign Up to like & getrecommendations! Published in 2022 at "Therapeutics and Clinical Risk Management"
DOI: 10.2147/tcrm.s263825
Abstract: Abstract Erenumab is a monoclonal antibody targeting the calcitonin gene-related peptide (CGRP) receptor suitable for episodic and chronic migraine prevention. Randomized clinical trials proved the superiority of erenumab to placebo in a strictly selected population,… read more here.
Keywords: prevention erenumab; erenumab focus; treatment; migraine prevention ... See more keywords